Syndax Pharmaceuticals Inc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Syndax Pharmaceuticals Inc has filed 653 SEC EDGAR filings since 06 Apr 2007

SEC filing history

Showing 76-100 of 652 matching filings.

Per page
25
Current page
4
SCHEDULE 13G/A File 005-89449

SCHEDULE 13G/A filing

Filing date
07 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-89449

SCHEDULE 13G/A filing

Filing date
17 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-37708

ARS

Filing date
01 Apr 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-37708

DEFA14A

Filing date
01 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37708

DEF 14A

Filing date
01 Apr 2025
Reporting date
01 Apr 2025
Next action
Verify source filing
4

4

Filing date
17 Mar 2025
Reporting date
14 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-89449

SCHEDULE 13G/A filing

Filing date
07 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Mar 2025
Reporting date
04 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37708

144 filing

Filing date
04 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-89449

SCHEDULE 13G/A filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Feb 2025
Reporting date
10 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Feb 2025
Reporting date
10 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Feb 2025
Reporting date
10 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-89449

SCHEDULE 13G filing

Filing date
12 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37708

144 filing

Filing date
10 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37708

144 filing

Filing date
10 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37708

144 filing

Filing date
10 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
07 Feb 2025
Reporting date
05 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
07 Feb 2025
Reporting date
05 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
07 Feb 2025
Reporting date
05 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .